Trade BioCryst - BCRX CFD

Trading Conditions

• Type: CFD
• Spread: 0.09
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 9.33
• Open: 9.27
• 1-Year Change: 28.39%
• Day's Range: 8.88 - 9.27

Trade BioCryst - BCRX CFD

What is BioCryst (BCRX)?

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on the design and development of novel small-molecule drugs for rare diseases. The company specializes in therapies targeting viral infections, oncology, and rare genetic disorders. BioCryst utilizes structure-based drug design and other advanced technologies to develop oral and intravenous treatments. Its product pipeline includes candidates in various stages of clinical development, aiming to address unmet medical needs. The company engages in research collaborations and partnerships to advance its therapeutic programs and expand its scientific capabilities.

BioCryst Stock Price Today: Live Overview

The price today is shaped by live market action as BioCryst trades at $9.09. It has moved within the range of $8.88 to $9.3, marking a daily change of -3.4225%.

FAQ: BioCryst (BCRX)

What is the current price of BCRX stock?

BioCryst's current price is $9.09.

Does BCRX pay dividends?

BioCryst pays dividends.

Does BCRX have a formal corporate presence or regional headquarters in the UAE?

BioCryst operates via partners in the UAE without an official regional office or subsidiary.

What is BCRX best known for?

BioCryst is most famous for its antiviral and rare disease therapies.

What assets are typically shown together with BCRX?

Commonly shown alongside BCRX: Attendo, iShares 7-10 Year Treasury Bond ETF, Korn Ferry